KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) FCF Margin (2016 - 2026)

Globus Medical filings provide 15 years of FCF Margin readings, the most recent being 30.08% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 1491.0% to 30.08% in Q4 2025 year-over-year; TTM through Dec 2025 was 25.18%, a 910.0% increase, with the full-year FY2025 number at 25.18%, up 910.0% from a year prior.
  • FCF Margin hit 30.08% in Q4 2025 for Globus Medical, down from 41.47% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 44.62% in Q4 2021 to a low of 1.04% in Q2 2022.
  • Median FCF Margin over the past 5 years was 17.26% (2022), compared with a mean of 20.08%.
  • Biggest five-year swings in FCF Margin: plummeted -2425bps in 2022 and later skyrocketed 2779bps in 2024.
  • Globus Medical's FCF Margin stood at 44.62% in 2021, then decreased by -8bps to 40.9% in 2022, then tumbled by -59bps to 16.79% in 2023, then dropped by -10bps to 15.17% in 2024, then soared by 98bps to 30.08% in 2025.
  • The last three reported values for FCF Margin were 30.08% (Q4 2025), 41.47% (Q3 2025), and 0.7% (Q2 2025) per Business Quant data.